{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:15:42Z","timestamp":1790946942480,"version":"4.1.0"},"reference-count":141,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00827","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T07:03:28Z","timestamp":1567062208000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":163,"title":["Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting"],"prefix":"10.3389","volume":"9","author":[{"given":"Panagiota","family":"Economopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kotsantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Psyrri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/jamaoncol.2016.4500","article-title":"Immune response to HPV16 E6 and E7 proteins and patient outcomes in head and neck cancer","volume":"3","author":"Nelson","year":"2016","journal-title":"JAMA Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"B3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/jnci\/djp017","article-title":"E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells","volume":"101","author":"Rampias","year":"2009","journal-title":"J Natl Cancer Inst."},{"key":"B4","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1200\/JCO.2004.00.3335","article-title":"Molecular classification identifies a subset of human papillomavirus\u2013associated oropharyngeal cancers with favorable prognosis","volume":"24","author":"Weinberger","year":"2006","journal-title":"J Clin Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3322\/canjclin.55.4.242","article-title":"TNM staging of cancers of the head and neck: striving for uniformity among diversity","volume":"55","author":"Patel","year":"2005","journal-title":"CA Cancer J Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1158\/0008-5472.CAN-12-3232","article-title":"Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures","volume":"72","author":"Kern","year":"2012","journal-title":"Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/PAP.0000000000000072","article-title":"New guideline for the reporting of studies developing, validating, or updating a multivariable clinical prediction model: the TRIPOD statement","volume":"22","author":"Moons","year":"2015","journal-title":"Adv Anat Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1001216","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PLoS Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1200\/JCO.2015.61.2358","article-title":"Human papillomavirus-associated oropharyngeal cancer: defining risk groups and clinical trials","volume":"33","author":"Bhatia","year":"2015","journal-title":"J Clin Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1749-4486.2006.01246.x","article-title":"Human papillomavirus and head and neck cancer: a systematic review and meta-analysis","volume":"31","author":"Hobbs","year":"2006","journal-title":"Clin Otolaryngol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/odi.12269","article-title":"Human papillomavirus and cancerous diseases of the head and neck: a systematic review and meta-analysis","volume":"21","author":"Saulle","year":"2015","journal-title":"Oral Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.oraloncology.2015.12.002","article-title":"Assessment of the total cfDNA and HPV16\/18 detection in plasma samples of head and neck squamous cell carcinoma patients","volume":"54","author":"Mazurek","year":"2016","journal-title":"Oral Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/jamaoncol.2015.2524","article-title":"Prognostic implication of persistent human papillomavirus type 16 DNA detection in oral rinses for human papillomavirus-related oropharyngeal carcinoma","volume":"1","author":"Rettig","year":"2015","journal-title":"JAMA Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1001\/jamaoto.2014.1338","article-title":"Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer","volume":"140","author":"Ahn","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.oraloncology.2008.01.001","article-title":"Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma","volume":"44","author":"Chuang","year":"2008","journal-title":"Oral Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1200\/JCO.2012.47.2738","article-title":"Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer","volume":"31","author":"Kreimer","year":"2013","journal-title":"J Clin Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1079\/PHN2002394","article-title":"European prospective investigation into cancer and nutrition (EPIC): study populations and data collection","volume":"5","author":"Riboli","year":"2002","journal-title":"Public Health Nutr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1001\/jamaoncol.2015.5504","article-title":"Associations of oral alpha-, beta-, and gamma-human papillomavirus types with risk of incident head and neck cancer","volume":"2","author":"Agalliu","year":"2016","journal-title":"JAMA Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/coa.13136","article-title":"Circulating human papillomavirus DNA as a surveillance tool in head and neck squamous cell carcinoma: a systematic review and meta-analysis","volume":"43","author":"Jensen","year":"2018","journal-title":"Clin Otolaryngol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/annonc\/mdy251","article-title":"Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer","volume":"29","author":"Hanna","year":"2018","journal-title":"Ann Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/1940-6207.CAPR-15-0299","article-title":"Serum antibodies to HPV16 early proteins warrant investigation as potential biomarkers for risk stratification and recurrence of HPV-associated oropharyngeal cancer","volume":"9","author":"Fakhry","year":"2016","journal-title":"Cancer Prev Res (Phila)."},{"key":"B23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.oraloncology.2017.02.004","article-title":"Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment","volume":"67","author":"Zhang","year":"2017","journal-title":"Oral Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1158\/1055-9965.EPI-08-0054","article-title":"Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?","volume":"17","author":"Smith","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/ijc.28194","article-title":"Markers of HPV infection and survival in patients with head and neck tumors","volume":"133","author":"Koslabova","year":"2013","journal-title":"Int J Cancer."},{"key":"B26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-9378-6-9","article-title":"Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study","volume":"6","author":"Rubenstein","year":"2011","journal-title":"Infect Agent Cancer."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1158\/1078-0432.CCR-16-1617","article-title":"E6 and E7 antibody levels are potential biomarkers of recurrence in patients with advanced-stage human papillomavirus-positive oropharyngeal squamous cell carcinoma","volume":"23","author":"Spector","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djx005","article-title":"Kinetics of the human papillomavirus type 16 E6 antibody response prior to oropharyngeal cancer","volume":"109","author":"Kreimer","year":"2017","journal-title":"J Natl Cancer Inst."},{"key":"B29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1158\/1055-9965.EPI-07-2597","article-title":"Association between p53 and human papillomavirus in head and neck cancer survival","volume":"17","author":"Smith","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1200\/EDBK_199697","article-title":"Major changes in head and neck staging for 2018","volume":"23","author":"Lydiatt","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book."},{"key":"B31","first-page":"149","article-title":"A new staging system for HPV-related oropharynx cancer: rationale, derivation, validation and practical applications","volume-title":"Clinical Issues in Head and Neck Oncology","author":"Huang","year":"2019"},{"key":"B32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","article-title":"Human papillomavirus testing in head and neck carcinomas: guideline from the college of american pathologists","volume":"142","author":"Lewis","year":"2018","journal-title":"Arch Pathol Lab Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1007\/s00405-017-4503-1","article-title":"Current and future techniques for human papilloma virus (HPV) testing in oropharyngeal squamous cell carcinoma","volume":"274","author":"Qureishi","year":"2017","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.oraloncology.2016.03.003","article-title":"Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus","volume":"56","author":"Zafereo","year":"2016","journal-title":"Oral Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/infdis\/jis698","article-title":"Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis","volume":"207","author":"Li","year":"2013","journal-title":"J Infect Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e3395","DOI":"10.7717\/peerj.3395","article-title":"Clinical impact of human papillomavirus in laryngeal squamous cell carcinoma: a retrospective study","volume":"5","author":"Chen","year":"2017","journal-title":"PeerJ."},{"key":"B39","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.oraloncology.2014.05.004","article-title":"Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas","volume":"50","author":"Westra","year":"2014","journal-title":"Oral Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-60761-947-5_4","article-title":"In situ detection of human papillomavirus DNA after PCR-amplification","volume":"688","author":"Nuovo","year":"2011","journal-title":"Methods Mol Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/dc.23668","article-title":"Fine-needle aspiration biopsy of HPV-related squamous cell carcinoma of the head and neck: current ancillary testing methods for determining HPV status","volume":"45","author":"Bernadt","year":"2017","journal-title":"Diagn Cytopathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1007\/s12105-012-0372-5","article-title":"HPV detection methods in head and neck cancer","volume":"6","author":"Venuti","year":"2012","journal-title":"Head Neck Pathol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/bjc.2013.63","article-title":"Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma","volume":"108","author":"Schache","year":"2013","journal-title":"Br J Cancer."},{"key":"B44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2014.192","article-title":"Emerging biomarkers in head and neck cancer in the era of genomics","volume":"12","author":"Kang","year":"2015","journal-title":"Nat Rev Clin Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/ijc.25174","article-title":"p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer","volume":"127","author":"Hoffmann","year":"2010","journal-title":"Int J Cancer."},{"key":"B46","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/PAS.0b013e318253a2d1","article-title":"Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials","volume":"36","author":"Jordan","year":"2012","journal-title":"Am J Surg Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/ijc.28580","article-title":"Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas","volume":"134","author":"Rietbergen","year":"2014","journal-title":"Int J Cancer."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/hed.25591","article-title":"HPV as a marker for molecular characterization in head and neck oncology: looking for a standardization of clinical use and of detection method(s) in clinical practice","volume":"41","author":"Bussu","year":"2019","journal-title":"Head Neck."},{"key":"B49","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1470-2045(13)70181-5","article-title":"Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial","volume":"14","author":"Vermorken","year":"2013","journal-title":"Lancet Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/annonc\/mdt319","article-title":"Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials","volume":"24","author":"Rietbergen","year":"2013","journal-title":"Ann Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.18.00684","article-title":"Human papillomavirus testing in head and neck carcinomas: ASCO clinical practice guideline endorsement of the college of american pathologists guideline","volume":"36","author":"Fakhry","year":"2018","journal-title":"J Clin Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1158\/1078-0432.CCR-11-0388","article-title":"Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination","volume":"17","author":"Schache","year":"2011","journal-title":"Clin Cancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/ijc.22980","article-title":"A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen","volume":"121","author":"Smeets","year":"2007","journal-title":"Int J Cancer."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cncr.27892","article-title":"Impact of positron emission tomography\/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence","volume":"119","author":"Ho","year":"2013","journal-title":"Cancer."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00259-011-1893-y","article-title":"Diagnostic performance of post-treatment FDG PET or FDG PET\/CT imaging in head and neck cancer: a systematic review and meta-analysis","volume":"38","author":"Gupta","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/cncr.20687","article-title":"The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor","volume":"101","author":"Rusthoven","year":"2004","journal-title":"Cancer."},{"key":"B57","first-page":"1","article-title":"Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma","volume":"33","author":"Castaldi","year":"2013","journal-title":"Acta Otorhinolaryngol Ital."},{"key":"B58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/hed.20942","article-title":"Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer","volume":"31","author":"Machtay","year":"2009","journal-title":"Head Neck."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00432-010-0972-y","article-title":"18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis","volume":"137","author":"Xie","year":"2011","journal-title":"J Cancer Res Clin Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000370331","article-title":"Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma","volume":"38","author":"Zhang","year":"2015","journal-title":"Oncol Res Treat."},{"key":"B61","first-page":"1907","article-title":"Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer","volume":"38","author":"Minn","year":"1997","journal-title":"J Nucl Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/hed.20130","article-title":"Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer","volume":"27","author":"Porceddu","year":"2005","journal-title":"Head Neck."},{"key":"B63","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2967\/jnumed.107.044792","article-title":"Clinical utility of 18F-FDG PET\/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer","volume":"49","author":"Ong","year":"2008","journal-title":"J Nucl Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1200\/jco.2011.29.15_suppl.5504","article-title":"Results of an ontario clinical oncology group (OCOG) prospective cohort study on the use of FDG PET\/CT to predict the need for neck dissection following radiation therapy of head and neck cancer (HNC)","volume":"15","author":"Waldron","year":"","journal-title":"J. Clin. Oncol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jamaoto.2013.607","article-title":"Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma","volume":"138","author":"Chan","year":"2012","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"B66","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.oraloncology.2013.12.003","article-title":"Reliability of post-chemoradiotherapy F-18-FDG PET\/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer","volume":"50","author":"Vainshtein","year":"2014","journal-title":"Oral Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijrobp.2017.01.018","article-title":"Re-evaluation of ipsilateral radiation for T1-T2N0-N2b tonsil carcinoma at the princess margaret hospital in the human papillomavirus era, 25 years later","volume":"98","author":"Huang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT surveillance versus neck dissection in advanced head and neck cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N Engl J Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1200\/JCO.2017.73.5845","article-title":"Fluorodeoxyglucose-positron emission tomography\/computed tomography after concurrent chemoradiotherapy in locally advanced head-and-neck squamous cell cancer: the ECLYPS study","volume":"35","author":"Van den Wyngaert","year":"2017","journal-title":"J Clin Oncol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2217\/iim.12.60","article-title":"FDG-PET\/CT imaging biomarkers in head and neck squamous cell carcinoma","volume":"4","author":"Paidpally","year":"2012","journal-title":"Imaging Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3322\/caac.21231","article-title":"Tobacco use and cessation for cancer survivors: an overview for clinicians","volume":"64","author":"Karam-Hage","year":"2014","journal-title":"CA Cancer J Clin."},{"key":"B72","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10555-017-9689-6","article-title":"Tobacco-related carcinogenesis in head and neck cancer","volume":"36","author":"Jethwa","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1158\/1055-9965.EPI-14-0311","article-title":"Smoking at diagnosis is an independent prognostic factor for cancer-specific survival in head and neck cancer: findings from a large, population-based study","volume":"23","author":"Sharp","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM199906103402301","article-title":"Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men","volume":"340","author":"Iribarren","year":"1999","journal-title":"N Engl J Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e0124045","DOI":"10.1371\/journal.pone.0124045","article-title":"Different levels in alcohol and tobacco consumption in head and neck cancer patients from 1957 to 2013","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS ONE."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/cncr.28588","article-title":"Causes of death in long-term survivors of head and neck cancer","volume":"120","author":"Baxi","year":"2014","journal-title":"Cancer."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1200\/JCO.2011.35.7301","article-title":"Population-based study of competing mortality in head and neck cancer","volume":"29","author":"Rose","year":"2011","journal-title":"J Clin Oncol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1056\/NEJM199301213280302","article-title":"Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer","volume":"328","author":"Browman","year":"1993","journal-title":"N Engl J Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ijrobp.2009.10.050","article-title":"Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome","volume":"79","author":"Chen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B82","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/toxsci\/kfi186","article-title":"The tobacco alkaloid nicotine demonstrates genotoxicity in human tonsillar tissue and lymphocytes","volume":"86","author":"Kleinsasser","year":"2005","journal-title":"Toxicol Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/1097-0142(20010915)92:6<1484::AID-CNCR1473>3.0.CO;2-W","article-title":"A comparison of published head and neck stage groupings in carcinomas of the tonsillar region","volume":"92","author":"Groome","year":"2001","journal-title":"Cancer."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1200\/JCO.2015.64.6448","article-title":"Proposed staging system for patients with HPV-related oropharyngeal cancer based on nasopharyngeal cancer N categories","volume":"34","author":"Dahlstrom","year":"2016","journal-title":"J Clin Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/annonc\/mdw226","article-title":"The promise of immunotherapy in head and neck squamous cell carcinoma","volume":"27","author":"Economopoulou","year":"2016","journal-title":"Ann Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science."},{"key":"B88","doi-asserted-by":"publisher","first-page":"17462","DOI":"10.18632\/oncotarget.3958","article-title":"CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1158\/1078-0432.CCR-14-1905","article-title":"Stromal CD8+ T-cell density-A promising supplement to TNM staging in non-small cell lung cancer","volume":"21","author":"Donnem","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"15179","DOI":"10.1038\/srep15179","article-title":"Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci Rep."},{"key":"B91","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00428-014-1630-6","article-title":"Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different","volume":"465","author":"Krupar","year":"2014","journal-title":"Virchows Arch."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e38711","DOI":"10.1371\/journal.pone.0038711","article-title":"Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer","volume":"7","author":"Nasman","year":"2012","journal-title":"PLoS ONE."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e965570","DOI":"10.4161\/21624011.2014.965570","article-title":"Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma","volume":"4","author":"Partlova","year":"2015","journal-title":"Oncoimmunology."},{"key":"B94","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/bjc.2013.639","article-title":"Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer","volume":"110","author":"Ward","year":"2014","journal-title":"Br J Cancer."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e1341030","DOI":"10.1080\/2162402X.2017.1341030","article-title":"Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV\/p16 in head and neck cancer treated with bio- or chemo-radiotherapy","volume":"6","author":"Ou","year":"2017","journal-title":"Oncoimmunology."},{"key":"B96","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/1078-0432.CCR-15-1543","article-title":"Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma","volume":"22","author":"Vassilakopoulou","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B97","first-page":"16","article-title":"Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers","volume":"8","author":"Uppaluri","year":"2008","journal-title":"Cancer Immun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/bjc.2013.640","article-title":"Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer","volume":"110","author":"Balermpas","year":"2014","journal-title":"Br J Cancer."},{"key":"B99","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ijc.29683","article-title":"CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: a multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)","volume":"138","author":"Balermpas","year":"2016","journal-title":"Int J Cancer."},{"key":"B100","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/bjc.2015.277","article-title":"Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma","volume":"113","author":"Oguejiofor","year":"2015","journal-title":"Br J Cancer."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e89829","DOI":"10.1172\/jci.insight.89829","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"1","author":"Mandal","year":"2016","journal-title":"JCI Insight."},{"key":"B102","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","article-title":"Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers","volume":"12","author":"Badoual","year":"2006","journal-title":"Clin Cancer Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/ijc.24923","article-title":"Unifying roles for regulatory T cells and inflammation in cancer","volume":"126","author":"Erdman","year":"2010","journal-title":"Int J Cancer."},{"key":"B104","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1200\/JCO.2008.19.6147","article-title":"In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer","volume":"27","author":"Pages","year":"2009","journal-title":"J Clin Oncol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12967-016-1029-z","article-title":"Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015","volume":"14","author":"Galon","year":"2016","journal-title":"J Transl Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.oraloncology.2014.11.014","article-title":"Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma","volume":"51","author":"Ritprajak","year":"2015","journal-title":"Oral Oncol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.oraloncology.2018.09.016","article-title":"The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: a systematic review and meta-analysis","volume":"86","author":"Yang","year":"2018","journal-title":"Oral Oncol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"52889","DOI":"10.18632\/oncotarget.17547","article-title":"PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma","volume":"8","author":"Muller","year":"2017","journal-title":"Oncotarget."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e0142656","DOI":"10.1371\/journal.pone.0142656","article-title":"High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS ONE."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/jamaoncol.2015.4685","article-title":"PD-L1 Testing in cancer: challenges in companion diagnostic development","volume":"2","author":"Hansen","year":"2016","journal-title":"JAMA Oncol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet."},{"key":"B114","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.1200\/JCO.2019.37.15_suppl.6000","article-title":"Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent\/metastatic head and neck squamous cell carcinoma (R\/M HNSCC)","volume":"37","author":"Rischin","year":"2019","journal-title":"J Clin Oncol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejca.2018.11.015","article-title":"Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: results from a single-arm, phase II study in patients with >\/ = 25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy","volume":"107","author":"Zandberg","year":"2019","journal-title":"Eur J Cancer."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3945\/ajcn.115.111203","article-title":"What is the best reference site for a single MRI slice to assess whole-body skeletal muscle and adipose tissue volumes in healthy adults?","volume":"102","author":"Schweitzer","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"B119","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/0148607113502674","article-title":"Prevalence of malnutrition and current use of nutrition support in patients with cancer","volume":"38","author":"Hebuterne","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"B120","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.oraloncology.2016.09.006","article-title":"Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients","volume":"62","author":"Swartz","year":"2016","journal-title":"Oral Oncol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00405-019-05361-4","article-title":"Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer","volume":"276","author":"Chargi","year":"2019","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.06.022.","article-title":"Agreement between skeletal muscle mass measurements using computed tomography imaging and magnetic resonance imaging in head and neck cancer patients","author":"Chargi","year":"2019","journal-title":"Oral Oncol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00405-019-05307-w","article-title":"Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra","volume":"276","author":"Bril","year":"2019","journal-title":"Eur Arch Otorhinolaryngol."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12443.","article-title":"CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer","author":"Zwart","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B125","doi-asserted-by":"publisher","first-page":"317","DOI":"10.21053\/ceo.2018.01613","article-title":"Diagnosis of sarcopenia in head and neck computed tomography: cervical muscle mass as a strong indicator of sarcopenia","volume":"12","author":"Ufuk","year":"2019","journal-title":"Clin Exp Otorhinolaryngol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/hed.25638","article-title":"Preoperative low skeletal muscle mass as a risk factor for pharyngocutaneous fistula and decreased overall survival in patients undergoing total laryngectomy","volume":"41","author":"Bril","year":"2019","journal-title":"Head Neck."},{"key":"B127","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/0003489418798660","article-title":"Neck muscle mass index as a predictor of post-laryngectomy wound complications","volume":"127","author":"Bozkurt","year":"2018","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamaoto.2017.0547","article-title":"Prognostic indication of sarcopenia for wound complication after total laryngectomy","volume":"143","author":"Achim","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"B129","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.oraloncology.2017.05.012","article-title":"Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer","volume":"71","author":"Wendrich","year":"2017","journal-title":"Oral Oncol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.radonc.2019.04.023","article-title":"The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation","volume":"137","author":"Ganju","year":"2019","journal-title":"Radiother Oncol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fonc.2018.00457","article-title":"Prognostic significance of sarcopenia with inflammation in patients with head and neck cancer who underwent definitive chemoradiotherapy","volume":"8","author":"Cho","year":"2018","journal-title":"Front Oncol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/hed.25420","article-title":"Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer","volume":"41","author":"Fattouh","year":"2019","journal-title":"Head Neck."},{"key":"B133","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/jamaoto.2019.1185","article-title":"Association between sarcopenia and mortality in patients undergoing surgical excision of head and neck cancer","volume":"145","author":"Stone","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"B134","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejca.2019.05.006","article-title":"Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer","volume":"116","author":"Jung","year":"2019","journal-title":"Eur J Cancer."},{"key":"B135","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/0194599818793857","article-title":"Clinical significance of sarcopenia among patients with advanced oropharyngeal cancer","volume":"160","author":"Tamaki","year":"2019","journal-title":"Otolaryngol Head Neck Surg."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science."},{"key":"B137","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1158\/2159-8290.CD-12-0537","article-title":"Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers","volume":"3","author":"Pickering","year":"2013","journal-title":"Cancer Discov."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.1206923","article-title":"Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1","volume":"333","author":"Agrawal","year":"2011","journal-title":"Science."},{"key":"B139","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1158\/2159-8290.CD-13-0103","article-title":"Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers","volume":"3","author":"Lui","year":"2013","journal-title":"Cancer Discov."},{"key":"B140","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","author":"Seiwert","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B141","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4143\/crt.2018.012","article-title":"Investigating the feasibility of targeted next-generation sequencing to guide the treatment of head and neck squamous cell carcinoma","volume":"51","author":"Lim","year":"2019","journal-title":"Cancer Res Treat."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00827\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T07:03:33Z","timestamp":1567062213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00827\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":141,"alternative-id":["10.3389\/fonc.2019.00827"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00827","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"article-number":"827"}}